Advancing Cancer Treatment
EIN: 832886283 · Moultonboro, NH · NTEE: G12
| Metric | Value |
|---|---|
| Total Revenue | $43K |
| Total Expenses | $1.3M |
| Net Assets | $1.5M |
Search Intent Cockpit
Advancing Cancer Treatment Form 990, Revenue, CEO Pay, and IRS Filing Signals
Advancing Cancer Treatment is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Advancing Cancer Treatment in one place.
Form 990 Filing Summary
5 filing years are available, with latest revenue of $2.1M and expenses of $1.3M.
Revenue and Expenses
Advancing Cancer Treatment reported $2.1M in revenue and $1.3M in expenses, a surplus of $808K.
Executive Compensation
Officer, director, trustee, and key employee pay is reviewed from IRS 990 compensation disclosures when present.
Charity Score and Red Flags
Mission score and red-flag review are shown when AI enrichment is available.
Is Advancing Cancer Treatment Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
IRS 990 Data Cockpit
Where the Money Comes From and Where It Goes
Revenue Source Mix
Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.
Expense Deployment
Functional expense detail is not available on the stored filing yet. Existing program percentage and future extracted expense fields will populate this panel.
Across stored filings, Advancing Cancer Treatment shows contribution history pending. Next enrichment targets: revenue-source fields, functional expense detail, IRS BMF classification, AI synthesis.
Decision Cockpit
One-Stop Donor, Research, and Peer Context Hub
| Decision Lens | Signal | What to Inspect Next |
|---|---|---|
| Legitimacy | Insufficient Data | Good filing record; no red flags identified |
| Mission spend | Pending | Unknown |
| Financial durability | Grade A | 5 stored filing years |
| Peer context | Compare with Hellenic Society Paideia Of New Hampshire | New Hampshire and Category G context |
Trust Check
Review legitimacy, deductibility, red flags, and filing consistency.
Open charity check →Peer Benchmark
Compare against real state and category peers.
Compare with Hellenic Society Paideia Of New Hampshire →All New Hampshire nonprofits
All Category G
Local and Sector Spokes
Move into this nonprofit's local market, category, and sector maps.
Moultonboro, NH nonprofitsCategory G in New Hampshire
Health in New Hampshire
Follow the Money
Jump into spending, compensation, rankings, and filing-year evidence.
State spending analysisState compensation analysis
Category G spending
Best Category G charities in New Hampshire
Relevant rankings
Donation Decision Flow
From Trust Check to Better Alternatives
Verify
Insufficient Data. Check deductibility, filings, and red flags.
2Understand money
Use filing data to inspect spending as enrichment grows.
3Compare
Benchmark against Hellenic Society Paideia Of New Hampshire.
4Decide
Build a shortlist, compare alternatives, and review the latest filing before giving.
Alternative Shopping
Similar Nonprofits Donors Should Compare
Hattie A & Fred C Lynam Trust 64
Concord, NH · $1.5M revenue · Score 95/100
Compare side-by-sideCouch Family Foundation
Hanover, NH · $35.9M revenue · Score 90/100
Compare side-by-sideRed Oak Montessori School Inc
Franklin, NH · $159K revenue · Score 90/100
Compare side-by-sideOrder Of The Eastern Star Of New Hampshire Grand Chapter
Nashua, NH · $1.0M revenue · Score 85/100
Compare side-by-sideNext Best Actions
Keep the Investigation Moving
About Advancing Cancer Treatment
Advancing Cancer Treatment (EIN: 832886283) is a nonprofit organization based in Moultonboro, NH, classified under NTEE code G12. The organization reported total revenue of $43K and total assets of $714K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Advancing Cancer Treatment's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Advancing Cancer Treatment is a micro nonprofit that has been operating for 7 years, with 5 years of IRS 990 filings on record (2019–2023). Revenue has grown at a compound annual rate of 36.0%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $2.1M |
| Total Expenses | $1.3M |
| Surplus / Deficit | +$808K |
| Total Assets | $1.5M |
| Total Liabilities | $30K |
| Net Assets | $1.5M |
| Operating Margin | 39.1% |
| Debt-to-Asset Ratio | 2.0% |
| Months of Reserves | 14.1 months |
Financial Health Grade: A
In 2023, Advancing Cancer Treatment reported a surplus of $808K with revenue exceeding expenses, holds 14.1 months of operating reserves (strong position), has a debt-to-asset ratio of 2.0% (very low leverage).
Financial Trends
Over 5 years of filings (2019–2023), Advancing Cancer Treatment's revenue has grown at a compound annual growth rate (CAGR) of 36.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -31.3% | -59.4% | +117.1% |
| 2022 | +100.7% | +278.6% | -41.9% |
| 2021 | -6.3% | -30.2% | +137.0% |
| 2020 | +164.7% | +119.7% | +607.5% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2019 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Advancing Cancer Treatment has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Advancing Cancer Treatment with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $808K, with revenue exceeding expenses.
- Debt-to-asset ratio: 2.0%.
Frequently Asked Questions about Advancing Cancer Treatment
Is Advancing Cancer Treatment a legitimate charity?
Advancing Cancer Treatment (EIN: 832886283) is a registered tax-exempt nonprofit based in New Hampshire. It has 5 years of IRS 990 filings on record. Total revenue: $43K. No red flags identified. Financial health grade: A.
How does Advancing Cancer Treatment spend its money?
Advancing Cancer Treatment reported $43K in total revenue in IRS 990 filings. 5 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Advancing Cancer Treatment tax-deductible?
Advancing Cancer Treatment is registered as a tax-exempt nonprofit (EIN: 832886283). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Advancing Cancer Treatment located?
Advancing Cancer Treatment is headquartered in Moultonboro, New Hampshire and files with the IRS under EIN 832886283. It is classified under NTEE code G12.
How many years of IRS 990 filings does Advancing Cancer Treatment have?
Advancing Cancer Treatment has 5 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $43K in total revenue.
Filing History
IRS 990 filing history for Advancing Cancer Treatment showing financial trends over 5 years of public records:
Over 5 years of IRS 990 filings (2019–2023), Advancing Cancer Treatment's revenue has grown by 242.2%, moving from $604K to $2.1M. Total assets increased by 2015% over the same period, from $70K to $1.5M. Total functional expenses rose by 135.9%, from $534K to $1.3M. In its most recent filing year (2023), Advancing Cancer Treatment reported a surplus of $808K, with revenue exceeding expenses. The organization holds $30K in liabilities against $1.5M in assets (debt-to-asset ratio: 2.0%), resulting in net assets of $1.5M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $2.1M | $1.3M | $1.5M | $30K | — | — |
| 2022 | $3.0M | $3.1M | $684K | $37K | — | View 990 |
| 2021 | $1.5M | $820K | $1.2M | $0 | — | View 990 |
| 2020 | $1.6M | $1.2M | $497K | $0 | — | View 990 |
| 2019 | $604K | $534K | $70K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $2.1M, expenses of $1.3M, and assets of $1.5M (revenue -31.3% year-over-year).
- 2022: Revenue of $3.0M, expenses of $3.1M, and assets of $684K (revenue +100.7% year-over-year).
- 2021: Revenue of $1.5M, expenses of $820K, and assets of $1.2M (revenue -6.3% year-over-year).
- 2020: Revenue of $1.6M, expenses of $1.2M, and assets of $497K (revenue +164.7% year-over-year).
- 2019: Revenue of $604K, expenses of $534K, and assets of $70K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Advancing Cancer Treatment:
Data Sources and Methodology
This transparency report for Advancing Cancer Treatment is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.